Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.[4]
The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end of 2021,[5] and in Canada in February 2022,[6] as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca.
^"Company Overview of Novavax, Inc". Bloomberg.com. Archived from the original on 24 February 2017. Retrieved 2 June 2019.
^"Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights - Feb 28, 2024". ir.novavax.com. Retrieved 1 May 2024.
^"Novavax Inc - Company Profile and News - Bloomberg Markets". Bloomberg.com.
^Novavax Inc. 2020 Annual Report Archived 14 August 2021 at the Wayback Machine. Accessed 10 May 2021.
^"EMA recommends Nuvaxovid for authorisation in the EU". European Medicines Agency (Press release). 20 December 2021. Retrieved 6 January 2022.
^"Health Canada authorizes Novavax's Nuvaxovid COVID-19 vaccine". Health Canada, Government of Canada. 17 February 2022. Retrieved 21 February 2022.
39°08′14″N 77°13′36″W / 39.1371°N 77.2267°W / 39.1371; -77.2267 Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland...
Institute of India has also reached an agreement with Novavax for the production of Novavax's NVX-CoV2373 (Covovax) vaccine for India and other low and...
initially teamed with Novavax Inc., a bio-technology company also based in Gaithersburg, MD., in the development and manufacture of the Novavax COVID-19 vaccine...
Indian-American vaccinologist who leads vaccine development at Novavax. She oversaw the development of the Novavax COVID-19 vaccine. Patel was born in Sojitra, a farming...
2020. Retrieved December 20, 2020. "Novavax Announces $1.6 Billion Funding from Operation Warp Speed". Novavax. July 7, 2020. Archived from the original...
through the COVAX facility under the WHO hospice. A recent agreement with Novavax expands its production for a second vaccine to 40 million doses in 2022...
saponin QS21, has been investigated for as an adjuvant for human vaccines. Novavax uses a highly purified quillaja extract as an adjuvant in its veterinary...
purchased two more vaccines from the pharmaceutical companies AstraZeneca and Novavax for New Zealand and its Pacific partners in addition to the existing stocks...
programming Yamaha NVX, several motorscooters in the Yamaha Aerox lineup Novavax, a pharmaceutical company which uses the product code "NVX-" Invoxia, an...
Global Information
US$983.7 million (2023)[2]